{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:51:49Z","timestamp":1794012709509,"version":"4.8.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The 1-h plasma glucose (1-h PG) during oral glucose tolerance test (OGTT) may enhance early dysglycemia detection compared with conventional markers. Distinct glucose curve morphologies correlate with glycemic profiles, insulin sensitivity, and \u03b2-cell function. We aimed to compare 1-h PG diagnostic performance with conventional methods and explored glucose curve morphology prevalence in a Brazilian population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective cross-sectional study analyzed 1,797 OGTT records from a Brazilian laboratory (2021\u20132024). Glycemic profiles were classified using 1-h PG, fasting plasma glucose (FPG), 2-h PG, and HbA1c according to American Diabetes Association, Brazilian Diabetes Society and International Diabetes Federation criteria. Cohen's \u03ba assessed inter-method agreement, McNemar\u2019s chi-square tests compared high glycemic risk detection and \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      tests evaluated associations between curve patterns (monophasic, biphasic, continuous rise) and glycemic status.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Participants were predominantly female (68.9%; mean age 49.6\u2009\u00b1\u200915.0\u00a0years). The 1-h PG identified 27.8% more intermediate hyperglycemia (IH)\/type 2 diabetes mellitus (T2DM) cases than FPG, 16.8% more than 2-h PG, and 26.7% more than HbA1c. The 1-h PG identified more individuals at high glycemic risk than FPG (\u03c7\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u2009290, p\u2009&lt;\u20090.001), HbA1c (\u03c7\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u2009129, p\u2009&lt;\u20090.001), 2-h PG (\u03c7\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u2009165, p\u2009&lt;\u20090.001), and their combined criteria. Among 1361 evaluable curves, 59.6% were monophasic, 38.3% biphasic, and 2.1% continuous rise\n                      <jats:bold>.<\/jats:bold>\n                      Monophasic curves predominated in IH\/T2DM, whereas biphasic curves were more frequent in normoglycemia (\u03c7\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u2009278; P\u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The 1-h PG thresholds\u2009\u2265\u20098.6 mmol\/L (155 mg\/dL) for IH and\u2009\u2265\u200911.6 mmol\/L (209 mg\/dL) for T2DM identified more dysglycemia cases than conventional methods, supporting early detection utility. Monophasic curve morphology was associated with impaired glycemic profiles, highlighting prognostic relevance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13098-025-01977-1","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:41:43Z","timestamp":1763138503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Diagnostic performance of 1-hour plasma glucose and glucose curve shape during oral glucose tolerance test: a cross-sectional study in a Brazilian cohort"],"prefix":"10.1186","volume":"17","author":[{"given":"Jo\u00e3o Pedro F. C.","family":"Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delanie B.","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rejane A.","family":"Magalhaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cec\u00edlia M. M.","family":"Figueir\u00eado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Petrola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena G.","family":"Teles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"1977_CR1","unstructured":"International Diabetes Federation. IDF Diabetes Atlas 11th Edition - 2025 diabetesatlas.org. Accessed 11 July 2025"},{"key":"1977_CR2","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.2337\/dci23-0052","volume":"46","author":"WH Herman","year":"2023","unstructured":"Herman WH, Ye W, American Diabetes Association Inc. Precision prevention of diabetes. Diabetes Care. 2023;46:1894\u20136.","journal-title":"Diabetes Care"},{"issue":"7","key":"1977_CR3","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.2337\/dc22-2376","volume":"46","author":"MR Rooney","year":"2023","unstructured":"Rooney MR, Fang M, Ogurtsova K, Ozkan B, Echouffo-Tcheugui JB, Boyko EJ, et al. Global prevalence of prediabetes. Diabetes Care. 2023;46(7):1388\u201394.","journal-title":"Diabetes Care"},{"issue":"48","key":"1977_CR4","first-page":"S27","volume":"1","author":"ADAPP Committee","year":"2025","unstructured":"Committee ADAPP. Diagnosis and classification of diabetes: standards of care in diabetes\u20142025. Diabetes Care. 2025;1(48):S27-49.","journal-title":"Diabetes Care"},{"key":"1977_CR5","doi-asserted-by":"crossref","unstructured":"Rodacki M, Cobas RA, Zajdenverg L, Silva J\u00fanior WS da, Giacaglia L, Calliari LE, et al. Diagn\u00f3stico de diabetes mellitus. In: Diretriz da Sociedade Brasileira de Diabetes. Conectando Pessoas; 2024.","DOI":"10.29327\/5412848.2024-1"},{"key":"1977_CR6","doi-asserted-by":"crossref","unstructured":"Bergman M, Buysschaert, Ceriello A, Mohan A, Sesti G. Current diagnostic criteria identify risk for type 2 diabetes too late. 2023 Apr. https:\/\/www.thelancet.com\/journals\/landia\/article\/PIIS2213-8587","DOI":"10.1016\/S2213-8587(23)00039-6"},{"key":"1977_CR7","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1210\/jc.2011-1894","volume":"97","author":"WH Herman","year":"2012","unstructured":"Herman WH, Cohen RM. Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes. J Clin Endocrinol Metab. 2012;97:1067\u201372.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1977_CR8","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.2337\/dc08-0225","volume":"31","author":"MA Abdul-Ghani","year":"2008","unstructured":"Abdul-Ghani MA, Ali N, Abdul-Ghani T, Defronzo RA. One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care. 2008;31(8):1650\u20135.","journal-title":"Diabetes Care"},{"issue":"8","key":"1977_CR9","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1210\/jc.2010-1698","volume":"96","author":"MA Abdul-Ghani","year":"2011","unstructured":"Abdul-Ghani MA, Abdul-Ghani T, M\u00fcller G, Bergmann A, Fischer S, Bornstein S, et al. Role of glycated hemoglobin in the prediction of future risk of T2DM. J Clin Endocrinol Metab. 2011;96(8):2596\u2013600.","journal-title":"J Clin Endocrinol Metab"},{"key":"1977_CR10","volume-title":"Diabetes Research and Clinical Practice","author":"M Bergman","year":"2024","unstructured":"Bergman M, Manco M, Satman I, Chan J, In\u00eas Schmidt M, Sesti G, et al. International diabetes federation position statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes. In: Diabetes Research and Clinical Practice. Dundrum: Elsevier Ireland Ltd; 2024."},{"key":"1977_CR11","doi-asserted-by":"crossref","unstructured":"Bergman M, Manco M, Sesti G, Del Prato S. Petition to replace current OGTT criteria for diagnosing prediabetes with the 1-hour post-load plasma glucose \u2265 155 mg\/dl (8.6 mmol\/L) Search for. Vol. 146, REVIEW \u2022. 2018.","DOI":"10.1016\/j.diabres.2018.09.017"},{"issue":"4","key":"1977_CR12","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00592-015-0829-6","volume":"53","author":"R Jagannathan","year":"2016","unstructured":"Jagannathan R, Sevick MA, Fink D, Dankner R, Chetrit A, Roth J, et al. The 1-hour post-load glucose level is more effective than HbA1c for screening dysglycemia. Acta Diabetol. 2016;53(4):543\u201350.","journal-title":"Acta Diabetol"},{"key":"1977_CR13","first-page":"203","volume":"1","author":"J Ha","year":"2023","unstructured":"Ha J, Chung ST, Bogardus C, Jagannathan R, Bergman M, Sherman AS. One-hour glucose is an earlier marker of dysglycemia than two-hour glucose. Diabetes Res Clin Pract. 2023;1:203.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"1977_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2337\/db24-0652","volume":"74","author":"J Lu","year":"2025","unstructured":"Lu J, Ni J, Su H, He X, Lu W, Zhu W, et al. One-hour postload glucose is a more sensitive marker of impaired b-cell function than two-hour postload glucose. Diabetes. 2025;74(1):36\u201342.","journal-title":"Diabetes"},{"issue":"4","key":"1977_CR15","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.2337\/dc20-1688","volume":"44","author":"V Ahuja","year":"2021","unstructured":"Ahuja V, Aronen P, Pramodkumar TA, Looker H, Chetrit A, Bloigu AH, et al. Accuracy of 1-hour plasma glucose during the oral glucose tolerance test in diagnosis of type 2 diabetes in adults: a meta-analysis. Diabetes Care. 2021;44(4):1062\u20139.","journal-title":"Diabetes Care"},{"key":"1977_CR16","volume-title":"Diabetes Metabolic Syndrome and Obesity","author":"R Jagannathan","year":"2020","unstructured":"Jagannathan R, Neves JS, Dorcely B, Chung ST, Tamura K, Rhee M, et al. The oral glucose tolerance test: 100 years later. In: Diabetes Metabolic Syndrome and Obesity. Macclesfield: Dove Medical Press Ltd; 2020."},{"issue":"6","key":"1977_CR17","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.2337\/dc17-1900","volume":"41","author":"E Paddock","year":"2018","unstructured":"Paddock E, Looker HC, Piaggi P, Knowler WC, Krakoff J, Chang DC. One-hour plasma glucose compared with two-hour plasma glucose in relation to diabetic retinopathy in American Indians. Diabetes Care. 2018;41(6):1212\u20137.","journal-title":"Diabetes Care"},{"key":"1977_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-019-0446-4","volume":"19","author":"X Cheng","year":"2019","unstructured":"Cheng X, Yang N, Li Y, Sun Q, Qiu L, Xu L, et al. The shape of the glucose response curve during an oral glucose tolerance test heralds \u03b2-cell function in a large Chinese population. BMC Endocr Disord. 2019;19:1.","journal-title":"BMC Endocr Disord"},{"issue":"4","key":"1977_CR19","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/jdi.13227","volume":"11","author":"H Kaga","year":"2020","unstructured":"Kaga H, Tamura Y, Takeno K, Kakehi S, Someya Y, Funayama T, et al. Shape of the glucose response curve during an oral glucose tolerance test is associated with insulin clearance and muscle insulin sensitivity in healthy non-obese men. J Diabetes Investig. 2020;11(4):874\u20137.","journal-title":"J Diabetes Investig"},{"key":"1977_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjdrc-2021-002264","volume":"9","author":"KM Utzschneider","year":"2021","unstructured":"Utzschneider KM, Younes N, Rasouli N, Barzilay JI, Banerji MA, Cohen RM, et al. Shape of the OGTT glucose response curve: relationship with \u03b2-cell function and differences by sex, race, and BMI in adults with early type 2 diabetes treated with metformin. BMJ Open Diabetes Res Care. 2021;9:1.","journal-title":"BMJ Open Diabetes Res Care."},{"issue":"4","key":"1977_CR21","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1210\/jc.2018-01828","volume":"104","author":"G Peddinti","year":"2019","unstructured":"Peddinti G, Bergman M, Tuomi T, Groop L. 1-hour post-OGTTglucose improves the early prediction of type 2 diabetes by clinical and metabolic markers. J Clin Endocrinol Metab. 2019;104(4):1131\u201340.","journal-title":"J Clin Endocrinol Metab"},{"key":"1977_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60619-X","author":"AG Tab\u00e1k","year":"2009","unstructured":"Tab\u00e1k AG, Jokela M, Akbaraly TN, Brunner EJ, Kivim\u00e4ki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet. 2009. https:\/\/doi.org\/10.1016\/S0140-6736(09)60619-X.","journal-title":"Lancet"},{"key":"1977_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13098-022-00865-2","volume":"14","author":"V Guerreiro","year":"2022","unstructured":"Guerreiro V, Maia I, Neves JS, Salazar D, Ferreira MJ, Mendon\u00e7a F, et al. Oral glucose tolerance testing at 1 h and 2 h: relationship with glucose and cardiometabolic parameters and agreement for pre-diabetes diagnosis in patients with morbid obesity. Diabetol Metab Syndr. 2022;14:1.","journal-title":"Diabetol Metab Syndr"},{"issue":"8","key":"1977_CR24","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/dme.13116","volume":"33","author":"M Bergman","year":"2016","unstructured":"Bergman M, Chetrit A, Roth J, Dankner R. One-hour post-load plasma glucose level during the OGTT predicts mortality: observations from the Israel study of glucose intolerance. Obes Hypertens Diabetic Med. 2016;33(8):1060\u20136.","journal-title":"Obes Hypertens Diabetic Med"},{"key":"1977_CR25","doi-asserted-by":"crossref","unstructured":"Orencia AJ, Daviglus ML, Dyer AR, Walsh M, Greenland P, Stamler J. One-Hour Postload Plasma Glucose and Risks of Fatal Coronary Heart Disease and Stroke among Nondiabetic Men and Women: The Chicago Heart Association Detection Project in Industry (CHA) Study. Download Full Issue. 1997; 50","DOI":"10.1016\/S0895-4356(97)00201-1"},{"issue":"1","key":"1977_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2337\/dc17-1351","volume":"41","author":"M Pareek","year":"2018","unstructured":"Pareek M, Bhatt DL, Nielsen ML, Jagannathan R, Eriksson KF, Nilsson PM, et al. Enhanced predictive capability of a 1-hour oral glucose tolerance test: a prospective population-based cohort study. Diabetes Care. 2018;41(1):171\u20137.","journal-title":"Diabetes Care"},{"key":"1977_CR27","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1001\/archinternmed.2011.183","volume":"171","author":"TE Strandberg","year":"2011","unstructured":"Strandberg TE, Pienim\u00e4ki T, Strandberg AY, Salomaa VV, Pitk\u00e4l\u00e4 KH, Tilvis RS, et al. One-hour glucose, mortality, and risk of diabetes: A 44-year prospective study in men. Archives Int Med. 2011;171:941\u20133.","journal-title":"Archives Int Med"},{"key":"1977_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12933-024-02394-w","volume":"23","author":"G Monea","year":"2024","unstructured":"Monea G, Jiritano R, Salerno L, Rubino M, Massimino M, Perticone M, et al. Compromised cardiac autonomic function in non-diabetic subjects with 1 h post-load hyperglycemia: a cross-sectional study. Cardiovasc Diabetol. 2024;23:295. https:\/\/doi.org\/10.1186\/s12933-024-02394-w.","journal-title":"Cardiovasc Diabetol"},{"key":"1977_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.947292","volume":"9","author":"L Rong","year":"2022","unstructured":"Rong L, Cheng X, Yang Z, Gong Y, Li C, Yan S, et al. One-hour plasma glucose as a long-term predictor of cardiovascular events and all-cause mortality in a Chinese older male population without diabetes: a 20-year retrospective and prospective study. Front Cardiovasc Med. 2022;9:947292. https:\/\/doi.org\/10.3389\/fcvm.2022.947292.","journal-title":"Front Cardiovasc Med"},{"key":"1977_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112075","volume":"222","author":"TV Fiorentino","year":"2025","unstructured":"Fiorentino TV, De Vito F, Natale RM, Sergi S, Rubino M, Cassano V, et al. Reduced glomerular filtration rate in individuals with intermediate hyperglycemia and type 2 diabetes as defined by 1-hour post-load glucose levels according to the newly released IDF criteria. Diabetes Res Clin Pract. 2025;222:112075. https:\/\/doi.org\/10.1016\/j.diabres.2025.112075.","journal-title":"Diabetes Res Clin Pract"},{"key":"1977_CR31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2337\/dc08-1264","volume":"32","author":"MA Abdul-Ghani","year":"2009","unstructured":"Abdul-Ghani MA, Lyssenko V, Tuomi T, Defronzo RA, Groop L. Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes results from the Botnia study. Diabetes Care. 2009;32:281\u20136.","journal-title":"Diabetes Care"},{"issue":"9","key":"1977_CR32","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.2337\/dc09-2261","volume":"33","author":"M Manco","year":"2010","unstructured":"Manco M, Panunzi S, Macfarlane DP, Golay A, Melander O, Konrad T, et al. One-hour plasma glucose identifies insulin resistance and \u03b2-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the relationship between insulin sensitivity and cardiovascular risk (RISC) study. Diabetes Care. 2010;33(9):2090\u20137.","journal-title":"Diabetes Care"},{"issue":"11","key":"1977_CR33","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00592-022-01963-3","volume":"59","author":"M Trento","year":"2022","unstructured":"Trento M, Passera P, Tomalino M, Cavallo F, Cavallo F, Cavallo G, et al. Screening prediabetes with 1-h plasma glucose: a cost-effectiveness analysis. Acta Diabetol. 2022;59(11):1435\u201344. https:\/\/doi.org\/10.1007\/s00592-022-01963-3.","journal-title":"Acta Diabetol"},{"issue":"18","key":"1977_CR34","first-page":"1","volume":"16","author":"ML de Andrade","year":"2018","unstructured":"de Andrade ML, Pavan Antoniolli L, Cittolin-Santos GF, Gerchman F. Distinct metabolic profile according to the shape of the oral glucose tolerance test curve is related to whole glucose excursion: a cross-sectional study. BMC Endocr Disord. 2018;16(18):1.","journal-title":"BMC Endocr Disord"},{"key":"1977_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1210\/jendso\/bvaf060","volume":"9","author":"LS Fischer","year":"2025","unstructured":"Fischer LS, Kiesswetter E, Brandl B, Skurk T, Hauner H, Volkert D, et al. Association of OGTT-curve shape with anthropometric, metabolic, and inflammatory parameters in healthy adults. J Endocr Soc. 2025;9:6.","journal-title":"J Endocr Soc"},{"issue":"8","key":"1977_CR36","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.2337\/dc16-0352","volume":"39","author":"JY Kim","year":"2016","unstructured":"Kim JY, Michaliszyn SF, Nasr A, Lee SJ, Tfayli H, Hannon T, et al. The shape of the glucose response curve during an oral glucose tolerance test heralds biomarkers of type 2 diabetes risk in obese youth. Diabetes Care. 2016;39(8):1431\u20139.","journal-title":"Diabetes Care"},{"issue":"4","key":"1977_CR37","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/dmrr.1084","volume":"26","author":"MA Abdul-Ghani","year":"2010","unstructured":"Abdul-Ghani MA, Lyssenko V, Tuomi T, DeFronzo RA, Groop L. The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetes. Diabetes Metab Res Rev. 2010;26(4):280\u20136.","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"1977_CR38","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4274\/jcrpe.galenos.2020.2020.0142","volume":"13","author":"LLG Saboli\u0107","year":"2021","unstructured":"Saboli\u0107 LLG, \u0160epec MP, Berkovi\u0107 MC, Stipan\u010di\u0107 G. Time to the peak, shape of the curve and combination of these glucose response characteristics during oral glucose tolerance test as indicators of early beta-cell dysfunction in obese adolescents. J Clin Res Pediatr Endocrinol. 2021;13(2):160\u20139.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"1977_CR39","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00650.2010","author":"A Tura","year":"2011","unstructured":"Tura A, Morbiducci U, Sbrignadello S, Winhofer Y, Pacini G, Kautzky-Willer A. Shape of glucose, insulin, C-peptide curves during a 3-h oral glucose tolerance test: any relationship with the degree of glucose tolerance? American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2011. https:\/\/doi.org\/10.1152\/ajpregu.00650.2010.","journal-title":"American Journal of Physiology-Regulatory, Integrative and Comparative Physiology"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01977-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-01977-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01977-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T02:03:19Z","timestamp":1763172199000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-025-01977-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1977"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-01977-1","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Comit\u00ea de \u00c9tica em Pesquisa (CEP). CAAE\u2014Certificado de Apresenta\u00e7\u00e3o de Aprecia\u00e7\u00e3o \u00c9tica \u2013 number: 85521024.5.0000.0229.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"428"}}